KIT actively to support new drug R&D.

Published: 2005-09-28 06:56:00

Updated: 2005-09-28 06:56:00

The Korea Institute of Toxicology (KIT), a government financed professional preclinical research institute, has introduced a screening service from the overseas for any drug toxicity by using DNA chips, thus activating to support the R&D of new drugs in the private industrial sector of Korea.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK